DVA
54
2
WMB
66
4
OXY
38
2
SLG
41
4
V
54
16
FFIV
64
-5
AMG
58
4
R
73
2
MTCH
77
26
APA
45
6
PFE
43
12
CVS
60
-8
FTI
69
3
IR
63
2
ADP
61
2
WFC
80
-2
MAC
51
5
PCG
53
2
HBI
61
5
MTB
71
2
DVA
54
2
WMB
66
4
OXY
38
2
SLG
41
4
V
54
16
FFIV
64
-5
AMG
58
4
R
73
2
MTCH
77
26
APA
45
6
PFE
43
12
CVS
60
-8
FTI
69
3
IR
63
2
ADP
61
2
WFC
80
-2
MAC
51
5
PCG
53
2
HBI
61
5
MTB
71
2
Financhill
Back

Lexicon Pharmaceuticals 10K Form

Buy
60

LXRX
Lexicon Pharmaceuticals

Last Price:
$0.85
Seasonality Move:
5.3%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LXRX News And Ratings

See the #1 stock for the next 7 days that we like better than LXRX

LXRX Financial Statistics

Sales & Book Value

Annual Sales: $31.1M
Cash Flow: $-43.8M
Price / Cash Flow: 0
Annual Sales: $0.34
Price / Book: 2.74

Profitability

EPS (TTM): -0.51000
Net Income (TTM): $-177.3M
Gross Margin: $30.5M
Return on Equity: -90.8%
Return on Assets: -51.91%

Lexicon Pharmaceuticals Earnings Forecast

Key Lexicon Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 26 years for LXRX is 98.02%.
  • The Selling, General & Administrative Expenses for LXRX have been equal to 460.42% of Gross Profit Margin.
  • The Research & Development expenses have been 271.81% of Revenue.
  • The Net Earning history of LXRX is -644.78% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 14 years.

Lexicon Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: LXRX
CUSIP: 528872
Website: lexpharma.com

Debt

Debt-to-Equity Ratio: 0.82
Current Ratio: 2.22
Quick Ratio: 2.19

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

LXRX Technical Analysis vs Fundamental Analysis

Buy
60
Lexicon Pharmaceuticals (LXRX) is a Buy

Is Lexicon Pharmaceuticals a Buy or a Sell?